Skip to main content

Advertisement

SpringerLink
Log in

Association of LAPTM4B gene polymorphism with nasopharyngeal carcinoma susceptibility in a Chinese population

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Lysosome-associated protein transmembrane-4 beta (LAPTM4B) is a novel cancer-related gene. It has two alleles designated LAPTM4B*1 and LAPTM4B*2. Previous studies have revealed that LAPTM4B polymorphisms contribute to the risk of many cancers. The aim of this study was to investigate the association between different LAPTM4B alleles and the risk of nasopharyngeal carcinoma (NPC), one of the most common cancers in southern China. Using polymerase chain reaction (PCR) in a case–control study, we detected the LAPTM4B genotype in peripheral blood samples from 134 patients with NPC and 327 control subjects. The chi-square test was used to analyze differences of categorical variables and Hardy–Weinberg equilibrium. Odds ratios and 95 % CI were computed using an unconditional logistic regression model. The frequency of allele *2 was 26.87 % in the NPC group, which was not significantly different from that of the control group (27.98 %, P = 0.867). Using the LAPTM4B*1/1 genotype as a reference, we found that the *1/2, *2/2 and *1/2 + *2/2 genotype were also not associated with the risk of NPC. No association was observed between LAPTM4B gene polymorphisms and the risk of NPC adjusted by gender and age. The results of our study indicated that the polymorphism of LAPTM4B gene did not influence the susceptibility of NPC in the Chinese population. Large-scale studies are needed to confirm our findings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Parkin DM, Muir CS. Cancer incidence in five continents. Comparability and quality of data. IARC Sci Publ. 1992;120:45–173.

    PubMed  Google Scholar 

  2. Yu MC, Yuan JM. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol. 2002;12(6):421–9.

    Article  PubMed  Google Scholar 

  3. Parkin DM, Läärä E, Muir CS. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer. 1988;41(2):184–97.

    Article  PubMed  CAS  Google Scholar 

  4. Skinner DW, Van Hasselt CA, Tsao SY. Nasopharyngeal carcinoma: modes of presentation. Ann Otol Rhinol Laryngol. 1991;100(7):544–51.

    PubMed  CAS  Google Scholar 

  5. Yuan JM, Wang XL, Xiang YB, et al. Non-dietary risk factors for nasopharyngeal carcinoma in Shanghai, China. Int J Cancer. 2000;85(3):364–9.

    Article  PubMed  CAS  Google Scholar 

  6. Burgos JS. Involvement of the Epstein-Barr virus in the nasopharyngeal carcinoma pathogenesis. Med Oncol. 2005;22(2):113–21.

    Article  PubMed  CAS  Google Scholar 

  7. Yuan JM, Wang XL, Xiang YB, et al. Preserved foods in relation to risk of nasopharyngeal carcinoma in Shanghai, China. Int J Cancer. 2000;85(3):358–63.

    Article  PubMed  CAS  Google Scholar 

  8. Feng BJ, Jalout M, Ayoub WB, et al. Dietary risk factors for nasopharyngeal carcinoma in Maghrebian countries. Int J Cancer. 2007;121(7):1550–5.

    Article  PubMed  CAS  Google Scholar 

  9. Lin TM, Chang HJ, Chen CJ, et al. Risk factors for nasopharyngeal carcinoma. Anticancer Res. 1986;6(4):791–6.

    PubMed  CAS  Google Scholar 

  10. Liu J, Zhou R, Zhang N, et al. Biological function of a novel gene overexpressed in human hepatocellular carcinoma. Chin Med J (Engl). 2000;113(10):881–5.

    CAS  Google Scholar 

  11. Shao GZ, Zhou RL, Zhang QY, et al. Molecular cloning and characterization of LAPTM4B, a novel gene upregulated in hepatocellular carcinoma. Oncogene. 2003;22(32):5060–9.

    Article  PubMed  CAS  Google Scholar 

  12. Vergarajauregui S, Martina JA, Puertollano R. LAPTMs regulate lysosomal function and interact with mucolipin 1: new clues for understanding mucolipidosis type IV. J Cell Sci. 2010;124(Pt3):459–68.

    Google Scholar 

  13. Kasper G, Vogel A, Klaman I, et al. The human LAPTM4b transcript is upregulated in various types of solid tumours and seems to play a dual functional role during tumour progression. Cancer Lett. 2005;224(1):93–103.

    Article  PubMed  CAS  Google Scholar 

  14. Yang H, Xiong FX, Qi RZ, et al. LAPTM4B-35 is a novel prognostic factor of hepatocellular carcinoma. J Surg Oncol. 2010;101(5):363–9.

    Article  PubMed  CAS  Google Scholar 

  15. Zhang G, Liang Y, Huang Y, et al. Elevated lysosome-associated protein transmembrane-4β-35 is an independent prognostic marker in pancreatic carcinoma. J Int Med Res. 2012;40(4):1275–83.

    PubMed  CAS  Google Scholar 

  16. Zhou L, He XD, Cui QC, et al. Expression of LAPTM4B-35: a novel marker of progression, invasiveness and poor prognosis of extrahepatic cholangiocarcinoma. Cancer Lett. 2008;264(2):209–17.

    Article  PubMed  CAS  Google Scholar 

  17. Yang Y, Yang H, McNutt MA, et al. LAPTM4B overexpression is an independent prognostic marker in ovarian carcinoma. Oncol Rep. 2008;20(5):1077–83.

    PubMed  Google Scholar 

  18. Meng FL, Yin MZ, Song HT, et al. LAPTM4B-35 overexpression is an independent prognostic marker in endometrial carcinoma. Int J Gynecol Cancer. 2010;20(5):745–50.

    Article  PubMed  Google Scholar 

  19. He J, Shao GZ, Zhou RL. Effects of the novel gene, LAPTM4B, highly expression in hepatocellular carcinoma on cell proliferation and tumorigenesis of NIH3T3 cells. Beijing Da Xue Xue Bao. 2003;35(4):348–52.

    PubMed  CAS  Google Scholar 

  20. Liu XR, Zhou RL, Zhang QY, et al. Identification and characterization of LAPTM4B encoded by a human hepatocellular carcinomaassociated novel gene. Beijing Da Xue Xue Bao. 2003;35(4):340–7.

    PubMed  CAS  Google Scholar 

  21. Zhai GJ, Yang H, Ji XX, et al. Correlation of LAPTM4B polymorphisms with hepatocellular carcinoma in Chinese patients. Med Oncol. 2012;29(4):2744–9.

    Article  PubMed  CAS  Google Scholar 

  22. Wang S, Zhang QY, Zhou RL. Relationship between LAPTM4B gene polymorphism and susceptibility of primary liver cancer. Ann Oncol. 2012;23(7):1864–9.

    Article  PubMed  CAS  Google Scholar 

  23. Deng LJ, Zhang QY, Liu B, et al. Relationship between LAPTM4B gene polymorphism and susceptibility of lung cancer. Beijing Da Xue Xue Bao. 2005;37(3):302–5.

    PubMed  CAS  Google Scholar 

  24. Liu Y, Zhang QY, Qian N, et al. Relationship between LAPTM4B gene polymorphism and susceptibility of gastric cancer. Ann Oncol. 2007;18(2):311–6.

    Article  PubMed  CAS  Google Scholar 

  25. Cheng XJ, Xu W, Zhang QY, et al. Relationship between LAPTM4B gene polymorphism and susceptibility of colorectal and esophageal cancers. Ann Oncol. 2008;19(3):527–32.

    Article  PubMed  Google Scholar 

  26. Sun L, Zhang QY, Liu Y, et al. Relationship between Human Novel Gene LAPTM4B Polymorphism and Susceptibility of Lymphoma. Cancer Res Prev Treat. 2007;34(4):245–8.

    CAS  Google Scholar 

  27. Meng FL, Song HT, Luo C, et al. Correlation of LAPTM4B polymorphisms with cervical carcinoma. Cancer. 2011;117(12):2652–8.

    Article  PubMed  CAS  Google Scholar 

  28. Yang H, Zhai GJ, Ji XX, et al. Correlation of LAPTM4B polymorphisms with gallbladder carcinoma susceptibility in Chinese patients. Med Oncol. 2012;29(4):2809–13.

    Article  PubMed  CAS  Google Scholar 

  29. Xu Y, Liu YD, Zhou RL, et al. LAPTM4B polymorphisms is associated with ovarian cancer susceptibility and its prognosis. Jpn J Clin Oncol. 2012;42(5):413–9.

    Article  PubMed  Google Scholar 

  30. Fan MR, Liu Y, Zhou RL, et al. Association of LAPTM4B gene polymorphism with breast cancer susceptibility. Cancer Epidemiol. 2012;36(4):364–8.

    Article  PubMed  CAS  Google Scholar 

  31. Li X, Kong X, Chen X, et al. LAPTM4B allele *2 is associated with breast cancer susceptibility and prognosis. PLoS One. 2012;7(9):e44916.

    Article  PubMed  Google Scholar 

  32. Li L, Wei XH, Pan YP, et al. LAPTM4B: a novel cancer associated gene motivates multidrug resistance through efflux and activating PI3 K/AKT signaling. Oncogene. 2010;29(43):5785–95.

    Article  PubMed  CAS  Google Scholar 

  33. Li Y, Zhang Q, Tian R, et al. Lysosomal transmembrane protein LAPTM4B promotes autophagy and tolerance to metabolic stress in cancer cells. Cancer Res. 2011;71(24):7481–9.

    Article  PubMed  CAS  Google Scholar 

  34. Li Y, Iglehart JD, Richardson AL, et al. The amplified cancer gene LAPTM4B promotes tumor growth and tolerance to stress through the induction of autophagy. Autophagy. 2012;8(2):273–4.

    Article  PubMed  CAS  Google Scholar 

  35. Peng C, Zhou RL, Shao GZ, et al. Expression of lysosome-associated protein transmembrane 4B–35 in cancer and its correlation with the differentiation status of hepatocellular carcinoma. World J Gastroenterol. 2005;11(18):2704–8.

    PubMed  CAS  Google Scholar 

  36. Shao GZ, Zhou RL, Zhang QY, et al. Molecular cloning and characterization of LAPTM4B, a novel gene upregulated in hepatocellular carcinoma. Oncogene. 2003;22(32):5060–9.

    Article  PubMed  CAS  Google Scholar 

  37. Hildesheim A, Levine PH. Etiology of nasopharyngeal carcinoma: a review. Epidemiol Rev. 1993;15(2):466–85.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by the National Natural Science Foundation of China (No. 81071422). We thank all the people and patients who participated in this study.

Competing interests

The authors declare that neither financial nor non-financial competing interests exist.

Author information

Authors and Affiliations

  1. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Clinical Laboratory, Peking University Cancer Hospital and Institute, 52 Fucheng Road, Haidian District, Beijing, 100142, People’s Republic of China

    Bing Wang, Jianjun Xu & Qingyun Zhang

  2. Department of Cell Biology, School of Basic Medical Sciences, Peking University, Beijing, China

    Rouli Zhou

Authors
  1. Bing Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jianjun Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rouli Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Qingyun Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Qingyun Zhang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, B., Xu, J., Zhou, R. et al. Association of LAPTM4B gene polymorphism with nasopharyngeal carcinoma susceptibility in a Chinese population. Med Oncol 30, 470 (2013). https://doi.org/10.1007/s12032-013-0470-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-013-0470-6

Keywords

Search

Navigation